Opinion: How federally funded research saved my son’s sight — and his life
If the NIH cuts continue, children diagnosed with rare, deadly diseases like retinoblastoma could pay a terrible price.
If the NIH cuts continue, children diagnosed with rare, deadly diseases like retinoblastoma could pay a terrible price.
